echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Blood System > Does APTT bleed if it continues to prolong? How many people have been misled

    Does APTT bleed if it continues to prolong? How many people have been misled

    • Last Update: 2022-10-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Preface

    Activated partial thromboplastin time (APTT) is at 37 °C, white clay activates XII.


    APTT prolongation has broad clinical implications and, therefore, is used as a routine monitoring program


    Case passed

    The patient, a 69-year-old male, was admitted to the hospital on August 3, 2022 for "weakness of the left limb and unclear speech for 1 day", diagnosed with large-scale cerebral infarction, previous manic psychosis for more than 40 years, and was treated with


    After admission, the patient repeatedly rechecked the coagulation function abnormally, mainly APTT prolongation, and the APTT results were shown in Figure 1 below

    Figure 1 APTT results of patients at different time periods

    Patients send a full set of coagulation factors: coagulation factors V.


    Figure 2 MDT consultation records

    Case studies

    It was an honor to be invited by the Director of the Department of Critical Care Medicine (NICU) of the Department of Neurology to participate in the clinical MDT, of course, before the MDT consultation, I also did a little homework, that is, to make up for the patient's correction test, the APTT correction test showed Rosner index (RI) = (A-B) ×100/C=43, RI>15, uncorrected, indicating the presence of an immediate effect of coagulation inhibitors (such as lupus anticoagulants, factor inhibitors, etc.


    Figure 3 Results of the patient APTT correction test

    According to the "Procedure of Activated Partial Thromboplastin Time Extension Mixed Plasma Correction Test and Interpretation of the Results of Chinese Experts"[1], the results of the correction test indicate the presence of lupus anticoagulants or factor inhibitors


    Figure 4 Correction test results and clinical significance

    Through corrective trials, I found that the patient was most likely APTT prolonged


    Case summary

    So look back and think about what exactly causes lupus anticoagulant positive, autoantibody positive, immunoglobulin abnormalities, autoimmune diseases, or long-term antipsychotic use? By consulting Zhang Fuyong, a teacher from the Affiliated Hospital of Guangxi Medical University, he told me that he had seen in the literature that antipsychotic depressants had been reported to induce the production of lupus anticoagulants, and later Teacher Zhang also found out the literature, it was reported that chlorpromazine drugs can increase IgM- anticardiolipin antibodies [2], Davis et al.


    So whether it is caused by this chlorpromazine drug in the end, it is not yet known, and more clinical studies are needed to confirm


    Expert reviews

    Xu Zhengmin is a professor at the School of Medicine of Xiangyang Vocational and Technical College

    Coagulation routine test is a compass for clinicians to determine whether the patient has a thrombosis or bleeding risk, once there is APTT or PT prolongation, the first thing that the clinic thinks of is the bleeding risk, but if the APTT is prolonged, there will be bleeding? Today this case is a continuous extension of APTT, can not be corrected, but the patient has not been bleeding case, through the correction of the trial initially determined that the patient is lupus anticoagulant caused by APTT prolongation, while the patient has coagulation factor antibodies, so the infusion of new plasma and cryoprecipitation can not correct the APTT results, this case has been tested and clinical MDT, the patient has been correctly treated, the importance of clinical cooperation between the visible test and the clinic, so we advocate the test to the clinical, participate in clinical consultation, Participating in MDT, although the distance is far away, the process is difficult, and there is still a lot of clinical knowledge that we need to learn, but as long as we bravely take the first step, the road is under the feet, the hope is ahead, and the step by step is down-to-earth, it will be closer and closer to the destination


    Thanks

    Thanks to Professor Zhang Fuyong of the First Affiliated Hospital of Guangxi Medical University for his analysis and guidance of this case, as well as the subsequent literature reference


    References

    [1] Thrombosis and Hemostasis Committee of the Chinese Society of Research Hospitals.


    Liu Yan,Deng Hongyu,Gao Zheshi.


    [3] Davis S, Kern HB, Asokan R.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.